International Speakers

Prof Krishna Chatterjee (UK)

Krishna Chatterjee is Professor of Endocrinology in the Institute of Metabolic Science at the University of Cambridge, Consultant Endocrinologist at Cambridge University Hospitals, and Director of the National Institute for Health Research (NIHR) Cambridge Clinical Research Facility. His research investigates rare, heritable disorders of thyroid hormone action, focussing on clinical features, molecular pathogenesis and therapy of syndromes of Resistance to Thyroid Hormone beta and alpha. He has translated his research into technologies (biochemical, genetic, biomarkers) that constitute an internationally recognised service for the diagnosis and management of these disorders.

Dr Jean-Claude Katte (Cameroon)

Dr Jean Claude Katte is a Wellcome Trust Early-Career Fellow and Translational Diabetes Scientist within the NIHR Global Health Diabetes Team at the University of Exeter Medical School. His research explores the heterogeneity and causes of young-onset diabetes forms in both native and immigrant African populations. He led the Young-Onset Diabetes in Sub-Saharan Africa (YODA) study, which recruited over 1,400 children and young adults; the largest of its kind in Africa, characterising the phenotype and pathogenesis of type 1 diabetes. He is also a Visiting Scholar at the University of Bristol’s Diabetes and Metabolism Lab, investigating novel islet autoantibody markers for type 1 diabetes. His Wellcome Trust Fellowship examines the unique characteristics and pathogenesis of non-autoimmune insulin-deficient diabetes subtypes in young Africans. He also serves as a Consultant Research Physician for the Changing Diabetes in Children (CDiC) programme in Cameroon. He holds an MD (University of Yaoundé 1) and a PhD (University of Exeter).

Prof Naveed Sattar (Scotland)

Professor Naveed Sattar is an internationally recognised leader in cardiometabolic medicine and clinical research. Based at the School of Cardiovascular and Metabolic Health at the University of Glasgow, he brings over three decades of expertise in diabetes, obesity, and cardiovascular disease prevention and management. Prof Sattar is an ISI Highly Cited Researcher and Fellow of the Academy of Medical Sciences, the Royal Society of Edinburgh, and the Royal Colleges of Pathologists and Physicians and Surgeons of Glasgow. His distinguished contributions to the field include receipt of the Edwin Bierman Award from the American Diabetes Association for outstanding scientific achievement in preventing macrovascular complications. His research spans epidemiology, mechanistic studies, and clinical trials, with particular expertise in cardiometabolic biomarkers and metabolic risk factors. Prof Sattar has significantly shaped clinical practice through his work, with numerous findings incorporated into UK and European guidelines. He currently chairs the UK Government's Obesity Mission and continues to lead a cardiovascular disease prevention clinic at Glasgow Royal Infirmary. With over 1,000 publications cited more than 296,000 times, Prof Sattar is recognised globally for his ability to challenge conventional wisdom and translate complex research into practical clinical insights.

Dr Emma Wilmot (UK)

Emma Wilmot (MB ChB BSc (hons) PhD FRCP) is an Associate Professor at the University of Nottingham, Honorary Consultant Diabetologist in Derby and founder of the Diabetes Technology Network UK. She has over 100 publications and has been Principal/Chief Investigator on a range of diabetes studies. Research interests include diabetes technology, structured education and type 2 diabetes in younger adults. She was previously awarded the University of Leicester medal for excellent PhD performance “Type 2 diabetes in younger adults”. As founder of the award-winning Association of British Clinical Diabetologists (ABCD) Diabetes Technology Network UK, she led the organisation to support improvements in access to diabetes technology in the UK. Emma is an ABCD committee member and DAFNE structured education executive board member. Emma is regularly invited to deliver national and international lectures.

Prof Lilian Witthauer (Switzerland)

Lilian Witthauer is an Assistant Professor with tenure track in Diabetes Technology at the University of Bern and Bern University Hospital, where she leads the samlab. She trained as a physicist at the University of Basel, earning a PhD in Experimental Physics, and completed a Master of Advanced Studies in Medical Physics at ETH Zürich. Before joining the University of Bern, she was a research fellow at Harvard Medical School and Massachusetts General Hospital (Wellman Center for Photomedicine), where she developed phosphorescence based oxygen sensing technologies for clinically relevant applications. Her research now focuses on optical and contactless sensing methods, sensor materials and system development, and data driven analysis to enable robust monitoring of physiological and metabolic processes, with a particular emphasis on diabetes and precision metabolic medicine. Her work is supported by competitive funding, including an SNSF funded programme in advanced sensing materials. She teaches in the Master Biomedical Engineering and Master Artifical Intelligence in Medicine and supervises students and researchers across Bachelor, Master, PhD, and postdoctoral levels.